Orexigen Therapeutics Inc (NASDAQ:OREX)

7.65
Delayed Data
As of 3:59pm ET
 +1.86 / +32.12%
Today’s Change
3.11
Today|||52-Week Range
9.37
+26.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues857.0K857.0K857.0K30.9M
 
 
 
 
 
Depreciation And Amortization10.0K8.0K38.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.8M24.0M23.6M17.8M
 
 
 
 
 
Research And Development15.5M17.0M16.7M10.7M
 
 
 
 
 
Total Operating Expenses21.8M24.0M23.7M17.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.0M-23.2M-22.8M13.0M
 
 
 
 
 
Interest Expense On Debt537.0K1.8M1.7M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.5M-24.9M-24.5M11.3M
 
 
 
 
 
Net Income-21.5M-24.9M-24.5M11.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS101.8M109.2M118.0M122.6M
 
 
 
 
 
Shares To Calculate EPS Diluted101.8M109.2M118.0M130.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.23-$0.21$0.09
 
 
 
 
 
EPS Diluted-$0.21-$0.23-$0.21$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account